The purpose of this study is to better understand how heart and blood vessel problems develop in people with Mucopolysaccharidosis (MPS). The investigators are looking at certain substances in the body called GAGs and proteoglycans to see how they affect the heart. The investigators also want to find reliable blood and urine markers that can help us track heart health and guide future treatments. This study aims to answer two main questions: 1. Do people with MPS show faster changes in their blood vessels over time (such as thickening or stiffening of the carotid artery) compared to people without MPS? 2. Do people with MPS have higher levels of certain proteins in their blood (such as clusterin and inflammatory markers) that are linked to blood vessel changes? What participants will do? Participants will complete the following tests once a year for 4 years: * Carotid ultrasound: an imaging test that looks at the blood vessels in the neck. * Echocardiogram: an ultrasound of the heart. * Blood draw * Urine collection These tests help the investigators track changes in heart and blood vessel health over time.
Study Type
OBSERVATIONAL
Enrollment
240
Children'S Hospital of Orange County
Orange, California, United States
RECRUITINGUniversity of Minnesota
Minneapolis, Minnesota, United States
NOT_YET_RECRUITINGSaint Louis University
St Louis, Missouri, United States
NOT_YET_RECRUITINGCardiac and Carotid Structure and Function
1\) We aim to annually assess cardiac and carotid structure and function utilizing ultrasonography, in participants with mucopolysaccharidoses and matched control participants
Time frame: Year 1, Year 2, Year 3, and Year 4
Measure biomarkers
2\) We aim to annually measure circulating levels of clusterin, elastin, cathepsin S, and cytokines in participants with mucopolysaccharidoses and matched control participants
Time frame: Year 1, Year 2, Year 3, and Year 4
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.